{"slug":"hansoh-pharmaceutical-group","name":"한소제약(翰森)","name_en":"Hansoh Pharmaceutical Group","ticker":"3692.HK","updated_at":"2026-07-11T10:21:29.56+00:00","canonical":"https://valuechain.wiki/hansoh-pharmaceutical-group","kicker":"항셍 지수","kicker_en":"Hang Seng Index","lead":"중국 대형 혁신 제약사로 항암, 중추신경계, 항감염 분야의 처방의약품을 개발·판매하는 기업이다. 항셍 지수 구성종목. 밸류체인 관계·수치 데이터는 조사 전인 기본 노드로, AI 질문 수요가 관측되면 상세 노드로 승격된다.","lead_en":"A large Chinese innovative pharma company developing prescription drugs in oncology, CNS, and anti-infectives. Hang Seng Index constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.","segments":{"parts":[{"name":"항암"},{"name":"중추신경계"},{"name":"항감염·대사"}],"total":"약 ¥101억 (FY2023)"},"segments_en":{"parts":[{"name":"Oncology"},{"name":"Central nervous system"},{"name":"Anti-infective & metabolic"}],"total":"approx. CN¥10.1B (FY2023)"},"returns_yearly":{"2021":-62.1,"2022":1.1,"2023":-26.1,"2024":55.2,"2025":118.5,"2026":-16.7},"return_asof":"2026-07-10","value_chain":{"leading":[],"benefiting":[],"analysis":null,"analysis_en":null,"analysis_asof":null},"edges":[]}